Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00689572 · ClinicalTrials.gov registry record · Phase 2
New Medication Treatment for Stimulant Dependence
A Phase 2 study, sponsored by University of Virginia.
- Completed
- Registry status
- Phase 2
- Development phase
- 108
- Enrollment target
NCT00689572 is a Phase 2 study that has completed, run by University of Virginia. The registered enrollment target is 108 participants.
The verdict
NCT00689572, a Phase 2 study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 108 participants
- Enrollment target
Study Summary
This study will evaluate the efficacy of ondansetron compared with placebo in the treatment of cocaine dependence.
Interventions
- DRUG Placebo
- DRUG Ondansetron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2008-07 |
| Est. Completion | 2013-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00689572
The ClinicalTrials.gov registry entry for NCT00689572 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00689572 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00689572 about?
NCT00689572 is a clinical study titled "New Medication Treatment for Stimulant Dependence". This study will evaluate the efficacy of ondansetron compared with placebo in the treatment of cocaine dependence.
What is the current status of trial NCT00689572?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 108 participants. The study started on 2008-07. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00689572?
The interventions under investigation include: Placebo (DRUG), Ondansetron (DRUG).
Who is sponsoring clinical trial NCT00689572?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.